Cargando…
Hyponatremia of non-small cell lung cancer: Indian experience
BACKGROUND: Hyponatremia is a hazardous complication of lung cancer and its treatment. It is seen at presentation in approximately 15% of patients with small-cell lung cancer (SCLC) and 1% of patients with non-small cell lung cancer (NSCLC). Platinum compounds used as first-line agents along with ta...
Autores principales: | Bose, Chinmoy K., Dey, Subhashis, Mukhopadhyay, Ashis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342719/ https://www.ncbi.nlm.nih.gov/pubmed/22557779 http://dx.doi.org/10.4103/0971-5851.92810 |
Ejemplares similares
-
Debating cancer: The paradox in cancer research
por: Mukhopadhyay, Ashis, et al.
Publicado: (2017) -
Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India
por: Chakraborty, Abhijit, et al.
Publicado: (2016) -
Hyponatremia as a prognostic factor in non-small cell lung cancer: a systematic review and meta-analysis
por: Sandfeld-Paulsen, Birgitte, et al.
Publicado: (2021) -
Severe hyponatremia as presenting symptom of small cell lung carcinoma
por: Stevchevska, Aleksandra, et al.
Publicado: (2023) -
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
por: Talreja, Vikas T., et al.
Publicado: (2020)